← Back
$NUVB All transactions

Nuvation Bio Inc.

▼ SELL 10b5-1 Plan

$ Value

$502K

Shares

100,000

Price

$5

Filed

Oct 29

Insider

Name

Hattersley Gary

Title

CHIEF SCIENTIFIC OFFICER

CIK

0001521111

Roles

Officer

Transaction Details

Transaction Date

2025-10-27

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

Shares sold pursuant to a 10b5-1 plan dated June 24, 2024. | Price reported is a weighted-average sales price. The shares were sold at prices ranging from $5.00 to $5.08. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. | Options vest as to 25% on July 1, 2020 and in equal monthly installments thereafter over the following three years.

Filing Info

Accession No.

0001521111-25-000003

Form Type

4

Issuer CIK

0001811063

Hattersley Gary's History

Date Ticker Type Value
2026-02-27 NUVB A $0
2025-11-20 NUVB M $120K
2025-11-20 NUVB $499K
2025-11-20 NUVB M $582K
2025-11-20 NUVB $2.2M
2025-11-20 NUVB M $0
2025-11-20 NUVB M $0
2025-10-27 NUVB M $174K
2025-10-27 NUVB $502K
2025-10-27 NUVB M $0

Other Insiders at NUVB (90d)

Insider Bought Sold Last
Hung David
PRESIDENT AND CEO
2026-02-27
Wentworth Kerry
CHIEF REGULATORY OFFICER
$1.1M 2026-04-17
Cui Xiangmin 2026-02-27
Hattersley Gary
CHIEF SCIENTIFIC OFFICER
2026-02-27
Markel Stacy
CHIEF PEOPLE OFFICER
2026-02-27
Hanley David C.
CHIEF TECHNICAL OPERATIONS
2026-02-27
Liu Dongfang
CHIEF MEDICAL OFFICER
$251K 2026-04-17
Makunje Moses
SEE REMARKS
2026-02-27
Sjogren Colleen
Chief Commercial Officer
2026-02-27
Sauvage Philippe
Chief Financial Officer
2026-02-27